Most strategy textbooks tell entrepreneurs they must choose between differentiating themselves with a superior product, great service, or the lowest cost to customers. That trade-off made more sense before software offered a way to achieve it all.
Fulgent Genetics (NASDAQ: FLGT) is bucking the old school approach by offering perhaps the most extensive lineup of genetic testing with unmatched customization. It is also using technology to drive down costs. Over time, this could give the company the best (and cheapest) offerings. So far, Fulgent is following a path that in the past has made a lot of shareholders rich.
Image source: Getty Images.
For further details see:
2 Numbers That Explain How This Hypergrowth Company Can Make You Rich